Literature DB >> 28944677

Multiplex and Label-Free Relative Quantification Approach for Studying Protein Abundance of Drug Metabolizing Enzymes in Human Liver Microsomes Using SWATH-MS.

Rohitash Jamwal1, Benjamin J Barlock1, Sravani Adusumalli1, Ken Ogasawara1, Brigitte L Simons2, Fatemeh Akhlaghi1.   

Abstract

We describe a sequential windowed acquisition of all theoretical fragment ion mass spectra (SWATH-MS) based method for label-free, simultaneous, relative quantification of drug metabolism enzymes in human liver microsomes (HLM; n = 78). In-solution tryptic digestion was aided by a pressure cycling method, which allowed a 90 min incubation time, a significant reduction over classical protocols (12-18 h). Digested peptides were separated on an Acquity UHPLC Peptide BEH C18 column using a 60 min gradient method at a flow rate of 0.100 mL/min. The quadrupole-time-of-flight mass spectrometer (ESI-QTOFMS) was operated in positive electrospray ionization mode, and data were acquired by data-dependent acquisition (DDA) and SWATH-MSALL mode. A pooled HLM sample was used as a quality control to evaluate variability in digestion and quantification among different batches, and inter-batch %CV for various proteins was between 3.1 and 7.8%. Spectral library generated from the DDA data identified 1855 distinct proteins and 25 681 distinct peptides at a 1% global false discovery rate (FDR). SWATH data were queried and analyzed for 10 major cytochrome P450 (CYP) enzymes using Skyline, a targeted data extraction software. Further, correlation analysis was performed between functional activity, protein, and mRNA expression for ten CYP enzymes. Pearson correlation coefficient (r) between protein and activity for CYPs ranged from 0.314 (CYP2C19) to 0.767 (CYP2A6). A strong correlation was found between CYP3A4 and CYP3A5 abundance and activity determined using midazolam and testosterone (r > 0.600, p < 0.001). Protein-to-activity correlation was moderate (r > 0.400-0.600, p < 0.001) for CYP1A2, CYP2A6, CYP2B6, CYP2C9, and CYP2E1 and significant but poor (r < 0.400, p < 0.05) for CYP2C8, CYP2C19, and CYP2D6. The findings suggest the suitability of SWATH-MS based method as a valuable and relatively fast analytical technique for relative quantification of proteins in complex biological samples. We also show that protein abundance is a better surrogate than mRNA to predict the activity of CYP activity.

Entities:  

Keywords:  CYP3A4; SWATH-MS; cytochrome-P450; human liver; label-free quantification; proteomics

Mesh:

Substances:

Year:  2017        PMID: 28944677     DOI: 10.1021/acs.jproteome.7b00505

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  12 in total

1.  Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver.

Authors:  Rohitash Jamwal; Suzanne M de la Monte; Ken Ogasawara; Sravani Adusumalli; Benjamin B Barlock; Fatemeh Akhlaghi
Journal:  Mol Pharm       Date:  2018-06-11       Impact factor: 4.939

2.  Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach.

Authors:  Sravani Adusumalli; Rohitash Jamwal; R Scott Obach; Tim F Ryder; Lorenzo Leggio; Fatemeh Akhlaghi
Journal:  Drug Metab Dispos       Date:  2019-06-10       Impact factor: 3.922

Review 3.  Data-independent acquisition (DIA): An emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters.

Authors:  Jiapeng Li; Logan S Smith; Hao-Jie Zhu
Journal:  Drug Discov Today Technol       Date:  2021-07-09

4.  Per- and polyfluoroalkyl substances (PFAS) augment adipogenesis and shift the proteome in murine 3T3-L1 adipocytes.

Authors:  Seyed Mohamad Sadegh Modaresi; Wei Wei; Marques Emily; Nicholas A DaSilva; Angela L Slitt
Journal:  Toxicology       Date:  2021-11-17       Impact factor: 4.221

5.  Perfluorooctanesulfonic Acid and Perfluorohexanesulfonic Acid Alter the Blood Lipidome and the Hepatic Proteome in a Murine Model of Diet-Induced Obesity.

Authors:  Marisa Pfohl; Lishann Ingram; Emily Marques; Adam Auclair; Benjamin Barlock; Rohitash Jamwal; Dwight Anderson; Brian S Cummings; Angela L Slitt
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

6.  Treprostinil alleviates hepatic mitochondrial injury during rat renal ischemia-reperfusion injury.

Authors:  Joyce Hou; Evelyn Tolbert; Mark Birkenbach; Nisanne S Ghonem
Journal:  Biomed Pharmacother       Date:  2021-09-21       Impact factor: 6.529

7.  Plasma Proteomic Analysis in Morquio A Disease.

Authors:  José V Álvarez; Susana B Bravo; María Pilar Chantada-Vázquez; Sofía Barbosa-Gouveia; Cristóbal Colón; Olalla López-Suarez; Shunji Tomatsu; Francisco J Otero-Espinar; María L Couce
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

8.  Treprostinil reduces mitochondrial injury during rat renal ischemia-reperfusion injury.

Authors:  Meiwen Ding; Evelyn Tolbert; Mark Birkenbach; Reginald Gohh; Fatemeh Akhlaghi; Nisanne S Ghonem
Journal:  Biomed Pharmacother       Date:  2021-07-15       Impact factor: 7.419

9.  Discovery of the Consistently Well-Performed Analysis Chain for SWATH-MS Based Pharmacoproteomic Quantification.

Authors:  Jianbo Fu; Jing Tang; Yunxia Wang; Xuejiao Cui; Qingxia Yang; Jiajun Hong; Xiaoxu Li; Shuang Li; Yuzong Chen; Weiwei Xue; Feng Zhu
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

10.  Biomarkers of tumor invasiveness in proteomics (Review).

Authors:  Daniel L Pouliquen; Alice Boissard; Olivier Coqueret; Catherine Guette
Journal:  Int J Oncol       Date:  2020-05-28       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.